Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Acute, Randomized, Double-blind, Controlled, Crossover Study to Investigate the Effect of an Arabinogalactan Product on Glucose and Insulin Response in Adults

NCT04005924 is registered in ClinicalTrials.gov with Biofortis, Merieux NutriSciences as lead sponsor.

NCT NCT04005924
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04005924 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Acute, Randomized, Double-blind, Controlled, Crossover Study to Investigate the Effect of an Arabinogalactan Product on Glucose and Insulin Response in Adults
Lead sponsor
Biofortis, Merieux NutriSciences
Phase
Not applicable
Overall status
Completed
Start date
May 6, 2019
Completion date
October 8, 2019
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

postprandial blood glucose